AtriCure Share Holder Equity 2010-2025 | ATRC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AtriCure share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AtriCure share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$220.2B
Boston Scientific (BSX)	$157B
Stryker (SYK)	$154B
EssilorLuxottica (ESLOY)	$136.6B
Medtronic (MDT)	$119.2B
Lonza Group Ag (LZAGY)	$50.3B
Haleon (HLN)	$44.4B
ResMed (RMD)	$40.3B
GE HealthCare Technologies (GEHC)	$35.5B
Agilent Technologies (A)	$34.1B
Terumo (TRUMY)	$25.8B
Koninklijke Philips (PHG)	$25.2B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$15B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.2B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.9B
Acuren (TIC)	$1.4B
Green Thumb Industries (GTBIF)	$1.3B